TMPRSS2:ERG gene fusion mRNAs have been associated with aggressive prostate cancer morphology in tissues [37] and a preliminary study using a combination of TMPRSS2:ERG plus PCA3 assays has shown synergistic diagnostic utility in urine specimens [19]. The gene discussed is PCA3; the disease is prostate carcinoma.